search
Back to results

A Modified Approach for Morbid Obese With Gynecologic Cancer

Primary Purpose

Malignant Neoplasm of Cervix, Endometrium and Ovary

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Approach for cancer resection
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malignant Neoplasm of Cervix, Endometrium and Ovary focused on measuring gynecologic cancer - panniculectomy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Resectable (ovarian, endometrial, cervical) cancers.
  2. Anaesthetically fit (ASA 1 and 2).
  3. Abdominal pannus below symphysis pubis.

Exclusion Criteria:

  1. Non resectable gynecologic cancer.
  2. Unfit patients.
  3. Patients who refuse to share in the trial.

Sites / Locations

  • Oncology center Mansoura UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Midline approach

Modified approach

Arm Description

Standard midline incision, then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).

Panniculectomy with vertical incision of the rectus sheath then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).

Outcomes

Primary Outcome Measures

Oncologic outcome
measured by number of lymph nodes retrieved and rate of optimal debulking.

Secondary Outcome Measures

Operative time
Postoperative procedure related morbidity
Wound and chest complications
Blood loss
intraoperative
Hospital stay

Full Information

First Posted
March 22, 2017
Last Updated
March 24, 2017
Sponsor
Mansoura University
search

1. Study Identification

Unique Protocol Identification Number
NCT03096652
Brief Title
A Modified Approach for Morbid Obese With Gynecologic Cancer
Official Title
Gynecologic Cancer: a Modified Approach for Morbid Obese Patients
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
August 2016 (undefined)
Primary Completion Date
August 2018 (Anticipated)
Study Completion Date
December 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Comparing standard midline approach with the modified approach in management of morbid obese patients with gynecologic cancers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malignant Neoplasm of Cervix, Endometrium and Ovary
Keywords
gynecologic cancer - panniculectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Midline approach
Arm Type
Active Comparator
Arm Description
Standard midline incision, then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).
Arm Title
Modified approach
Arm Type
Active Comparator
Arm Description
Panniculectomy with vertical incision of the rectus sheath then optimal debulking (hysterectomy + lymphadenectomy +/- omentectomy).
Intervention Type
Procedure
Intervention Name(s)
Approach for cancer resection
Primary Outcome Measure Information:
Title
Oncologic outcome
Description
measured by number of lymph nodes retrieved and rate of optimal debulking.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Operative time
Time Frame
1 day
Title
Postoperative procedure related morbidity
Description
Wound and chest complications
Time Frame
1 month
Title
Blood loss
Description
intraoperative
Time Frame
1 day
Title
Hospital stay
Time Frame
1 month

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Resectable (ovarian, endometrial, cervical) cancers. Anaesthetically fit (ASA 1 and 2). Abdominal pannus below symphysis pubis. Exclusion Criteria: Non resectable gynecologic cancer. Unfit patients. Patients who refuse to share in the trial.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Islam H Metwally, MSc, MRCS
Phone
01002985865
Ext
020
Email
drislamhany@mans.edu.eg
Facility Information:
Facility Name
Oncology center Mansoura University
City
Mansoura
State/Province
Dakahlia
ZIP/Postal Code
35516
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Islam H Metwally, MSc, MRCS
Phone
01002985865
Ext
020
Email
drislamhany@mans.edu.eg
First Name & Middle Initial & Last Name & Degree
Ahmed AbdAllah, MD
First Name & Middle Initial & Last Name & Degree
Amr F Elalfy, MSc
First Name & Middle Initial & Last Name & Degree
Shadi Awny, MSc
First Name & Middle Initial & Last Name & Degree
Mohamed Zuhdy, MSc
First Name & Middle Initial & Last Name & Degree
Mahmoud Mostafa, MSc
First Name & Middle Initial & Last Name & Degree
Sameh Roshdy, MD
First Name & Middle Initial & Last Name & Degree
Islam H Metwally, MSc, MRCS

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Modified Approach for Morbid Obese With Gynecologic Cancer

We'll reach out to this number within 24 hrs